Clinical Obesity Research Panel (CORP)
Background
The NIDDK Clinical Obesity Research Panel (CORP) is the successor to the National Task Force on Prevention and Treatment of Obesity, which was in existence from June 1991 until June 2003. The NIDDK CORP, composed of leading obesity researchers and clinicians, is charged with providing advice to the NIDDK Advisory Council on important clinical research needs related to obesity prevention and treatment, including their relative priority and costs, and identifies concepts for future clinical studies of obesity. The CORP serves in an advisory capacity to the Weight-control Information Network and may suggest topics for NIDDK-sponsored workshops and develop papers on topics related to clinical aspects of obesity. The CORP is placed organizationally under the auspices of the NIDDK Advisory Council and a member of the NIDDK Advisory Council serves on the CORP as a liaison member.
Roster
Steven N. Blair, PED Director of Epidemiology Cooper Institute 12330 Preston Road Dallas, TX 75230
Matthew W. Gillman, MD, SM Director, Obesity Prevention Program Associate Professor Department of Ambulatory Care and Prevention Harvard Medical School/Harvard Pilgrim Health Care 133 Brookline Avenue, 6th Floor Boston, MA 02215
Lee M. Kaplan, MD, PhD Associate Professor of Medicine Director, Weight Center 50 Staniford St, 4th Floor Boston, MA 02114
Samuel Klein, M.D. Professor of Medicine and Nutritional Science Director, Center for Human Nutrition Washington University School of Medicine 660 S. Euclid Avenue Campus Box 8031 St. Louis, MO 63110
Rudolph L. Leibel, M.D. Professor of Pediatrics and Medicine Head Division of Molecular Genetics Columbia University College of Physicians And Surgeons , Box 10 Russ Berrie Medical Science Pavilion 1150 Nicholas Avenue New York, NY 10032 |
Nico Pronk, Ph.D., FACSM, FAWHP Vice President, Center for Health Promotion Research Investigator, HealthPartners Research Foundation HealthPartners 8100 34th Avenue South P.O. Box 1309 Minneapolis, MN 55440-1309 Alan R. Shuldiner, MD John Whitehurst Professor of Medicine Head, Division of Endocrinology, Diabetes and Nutrition Director, Program in Genetics and Genomic Medicine University of Maryland School of Medicine Howard Hall, Room 494 660 Redwood St Baltimore, MD 21202
Patrick Powling Tso, Ph.D. Professor Department of Pathology Genome Research Institute University of Cincinnati College of Medicine 2120 East Galbraith Road Cincinnati, OH 45237
Delia Smith West, PhD Professor, Health Behavior College of Public Health 4301 West Markham St, #820 Little Rock, AR 72205
|
[Top]
Contact
For more information, please contact the Executive Director of the CORP, Dr. Susan Yanovski.
Reports
- Very Low-Calorie Diets
Objective: To provide an overview of the published scientific information on the safety and efficacy of very low-calorie diets (VLCDs) and to provide rational recommendations for their use.
JAMA. 1993;270:967-974.
Reprints available from: Weight-control Information Network
- Weight Cycling
Objective: To address concerns about the effects of weight cycling and to provide guidance on the risk-to-benefit ratio of attempts at weight loss, given current scientific knowledge.
JAMA, 1994;272:1196-1202.
Reprints available from: Weight-control Information Network
- Towards Prevention of Obesity: Research Directions
Objective: The research initiatives and future directions presented in this paper were developed by The National Task Force on Prevention and Treatment of Obesity, appointed by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health. Five conceptual goals for obesity research were formulated for translation into action over the long term. These goals reflect a developing convergence of ideas from diverse sectors of the obesity research community and provide the overall direction for future research emphases.
Obesity Research, 1994;6:571-584.
Reprints available from: Weight-control Information Network
- Long-term Pharmacotherapy in the Management of Obesity
Objective: To examine the rationale for long-term use of medications in the management of obesity, to provide an overview of published scientific information on their safety and efficacy, and to provide guidance to patients and practitioners regarding risks and benefits of treatment.
JAMA, 1996;276:1907-1915.
Reprints available from: Weight-control Information Network
[Top]
Page last updated: October 24, 2008